Cargando…
Circulating thymus and activation-regulated chemokine/CC chemokine ligand 17 is a strong candidate diagnostic marker for interstitial lung disease in patients with malignant tumors: a result from a pilot study
INTRODUCTION: Serum Krebs von den Lungen-6 (KL-6) level is an established diagnostic marker of interstitial lung disease (ILD). However, it is also elevated in patients with non-small cell lung cancer (NSCLC). The significance of circulating thymus and activation-regulated chemokine (TARC)/CC chemok...
Autores principales: | Yamane, Hiromichi, Ochi, Nobuaki, Yamagishi, Tomoko, Honda, Yoshihiro, Takeyama, Masami, Takigawa, Nagio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4476489/ https://www.ncbi.nlm.nih.gov/pubmed/26124663 http://dx.doi.org/10.2147/TCRM.S82995 |
Ejemplares similares
-
Drug-induced interstitial lung disease in the treatment of malignant lymphoma as a potential diagnostic marker: a comparison of serum Krebs von Lungen-6 and thymus and activation-regulated chemokine/CC chemokine ligand 17
por: Yamane, Hiromichi, et al.
Publicado: (2018) -
Epiphora in lung cancer patients receiving docetaxel: a case series
por: Yamagishi, Tomoko, et al.
Publicado: (2014) -
Obstructive jaundice caused by intraductal metastasis of lung adenocarcinoma
por: Ochi, Nobuaki, et al.
Publicado: (2014) -
High Uptake of FDG Along a Biliary Stent
por: Nagasaki, Yasunari, et al.
Publicado: (2016) -
Patients with osteosarcoma and soft tissue sarcoma might become “cancer refugees” in some Japanese regional cities
por: Yamane, Hiromichi, et al.
Publicado: (2018)